Clinical Outcomes for Endovascular Repair of Thoracic Aortic Disease Using the Seal Thoracic Stent Graft: A Korean Multicenter Retrospective Study

Myung Gyu Song, Young Kwon Cho, Do Yun Lee, Sung Bum Cho, Hyun Ki Yoon, Se Hwan Kwon, Hyo Cheol Kim, Chang Jin Yoon

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Purpose To investigate the midterm outcomes of thoracic endovascular aneurysm repair (TEVAR) with the use of the Seal stent graft for four categories of thoracic aortic disease. Materials and Methods This retrospective multicenter study evaluated the records of 216 Korean patients who underwent TEVAR with the Seal stent graft during 2007–2010. The study outcomes were (i) perioperative death, (ii) endoleak, (iii) repeat intervention, (iv) aortic-related death, and (v) all sudden unexplained late deaths. Results The overall technical success rate was 94% (203 cases), and the disease-specific rates were 97% (88 cases) for aneurysms, 96% (71 cases) for dissections, 82% (32 cases) for traumatic aortic disease, and 100% (12 cases) for intramural hematoma and/or penetrating aortic ulcer. There were 6 acute surgical conversions (2 for aneurysms and 4 for dissections). There were 18 endoleaks, 4 retrograde ascending aortic dissections, and 6 stent graft–induced new entries. The 1-, 3-, and 5-year overall survival rates were 93% ± 3, 90% ± 4, and 90% ± 4, respectively. Conclusions TEVAR with the Seal thoracic stent graft provided a high technical success rate and low mortality and complication rates during midterm follow-up. However, additional long-term studies are needed to evaluate the durability and late complications associated with this device.

Original languageEnglish
Pages (from-to)645-654
Number of pages10
JournalJournal of Vascular and Interventional Radiology
Volume28
Issue number5
DOIs
Publication statusPublished - 2017 May 1

Fingerprint

Thoracic Diseases
Aortic Diseases
Multicenter Studies
Stents
Aneurysm
Thorax
Retrospective Studies
Transplants
Endoleak
Dissection
Hematoma
Ulcer
Survival Rate
Outcome Assessment (Health Care)
Equipment and Supplies
Mortality

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Cardiology and Cardiovascular Medicine

Cite this

Clinical Outcomes for Endovascular Repair of Thoracic Aortic Disease Using the Seal Thoracic Stent Graft : A Korean Multicenter Retrospective Study. / Song, Myung Gyu; Cho, Young Kwon; Lee, Do Yun; Cho, Sung Bum; Yoon, Hyun Ki; Kwon, Se Hwan; Kim, Hyo Cheol; Yoon, Chang Jin.

In: Journal of Vascular and Interventional Radiology, Vol. 28, No. 5, 01.05.2017, p. 645-654.

Research output: Contribution to journalArticle

@article{d2d7c6b4dcd2476197aa04db37ac9a00,
title = "Clinical Outcomes for Endovascular Repair of Thoracic Aortic Disease Using the Seal Thoracic Stent Graft: A Korean Multicenter Retrospective Study",
abstract = "Purpose To investigate the midterm outcomes of thoracic endovascular aneurysm repair (TEVAR) with the use of the Seal stent graft for four categories of thoracic aortic disease. Materials and Methods This retrospective multicenter study evaluated the records of 216 Korean patients who underwent TEVAR with the Seal stent graft during 2007–2010. The study outcomes were (i) perioperative death, (ii) endoleak, (iii) repeat intervention, (iv) aortic-related death, and (v) all sudden unexplained late deaths. Results The overall technical success rate was 94{\%} (203 cases), and the disease-specific rates were 97{\%} (88 cases) for aneurysms, 96{\%} (71 cases) for dissections, 82{\%} (32 cases) for traumatic aortic disease, and 100{\%} (12 cases) for intramural hematoma and/or penetrating aortic ulcer. There were 6 acute surgical conversions (2 for aneurysms and 4 for dissections). There were 18 endoleaks, 4 retrograde ascending aortic dissections, and 6 stent graft–induced new entries. The 1-, 3-, and 5-year overall survival rates were 93{\%} ± 3, 90{\%} ± 4, and 90{\%} ± 4, respectively. Conclusions TEVAR with the Seal thoracic stent graft provided a high technical success rate and low mortality and complication rates during midterm follow-up. However, additional long-term studies are needed to evaluate the durability and late complications associated with this device.",
author = "Song, {Myung Gyu} and Cho, {Young Kwon} and Lee, {Do Yun} and Cho, {Sung Bum} and Yoon, {Hyun Ki} and Kwon, {Se Hwan} and Kim, {Hyo Cheol} and Yoon, {Chang Jin}",
year = "2017",
month = "5",
day = "1",
doi = "10.1016/j.jvir.2016.12.1227",
language = "English",
volume = "28",
pages = "645--654",
journal = "Journal of Vascular and Interventional Radiology",
issn = "1051-0443",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - Clinical Outcomes for Endovascular Repair of Thoracic Aortic Disease Using the Seal Thoracic Stent Graft

T2 - A Korean Multicenter Retrospective Study

AU - Song, Myung Gyu

AU - Cho, Young Kwon

AU - Lee, Do Yun

AU - Cho, Sung Bum

AU - Yoon, Hyun Ki

AU - Kwon, Se Hwan

AU - Kim, Hyo Cheol

AU - Yoon, Chang Jin

PY - 2017/5/1

Y1 - 2017/5/1

N2 - Purpose To investigate the midterm outcomes of thoracic endovascular aneurysm repair (TEVAR) with the use of the Seal stent graft for four categories of thoracic aortic disease. Materials and Methods This retrospective multicenter study evaluated the records of 216 Korean patients who underwent TEVAR with the Seal stent graft during 2007–2010. The study outcomes were (i) perioperative death, (ii) endoleak, (iii) repeat intervention, (iv) aortic-related death, and (v) all sudden unexplained late deaths. Results The overall technical success rate was 94% (203 cases), and the disease-specific rates were 97% (88 cases) for aneurysms, 96% (71 cases) for dissections, 82% (32 cases) for traumatic aortic disease, and 100% (12 cases) for intramural hematoma and/or penetrating aortic ulcer. There were 6 acute surgical conversions (2 for aneurysms and 4 for dissections). There were 18 endoleaks, 4 retrograde ascending aortic dissections, and 6 stent graft–induced new entries. The 1-, 3-, and 5-year overall survival rates were 93% ± 3, 90% ± 4, and 90% ± 4, respectively. Conclusions TEVAR with the Seal thoracic stent graft provided a high technical success rate and low mortality and complication rates during midterm follow-up. However, additional long-term studies are needed to evaluate the durability and late complications associated with this device.

AB - Purpose To investigate the midterm outcomes of thoracic endovascular aneurysm repair (TEVAR) with the use of the Seal stent graft for four categories of thoracic aortic disease. Materials and Methods This retrospective multicenter study evaluated the records of 216 Korean patients who underwent TEVAR with the Seal stent graft during 2007–2010. The study outcomes were (i) perioperative death, (ii) endoleak, (iii) repeat intervention, (iv) aortic-related death, and (v) all sudden unexplained late deaths. Results The overall technical success rate was 94% (203 cases), and the disease-specific rates were 97% (88 cases) for aneurysms, 96% (71 cases) for dissections, 82% (32 cases) for traumatic aortic disease, and 100% (12 cases) for intramural hematoma and/or penetrating aortic ulcer. There were 6 acute surgical conversions (2 for aneurysms and 4 for dissections). There were 18 endoleaks, 4 retrograde ascending aortic dissections, and 6 stent graft–induced new entries. The 1-, 3-, and 5-year overall survival rates were 93% ± 3, 90% ± 4, and 90% ± 4, respectively. Conclusions TEVAR with the Seal thoracic stent graft provided a high technical success rate and low mortality and complication rates during midterm follow-up. However, additional long-term studies are needed to evaluate the durability and late complications associated with this device.

UR - http://www.scopus.com/inward/record.url?scp=85014055922&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85014055922&partnerID=8YFLogxK

U2 - 10.1016/j.jvir.2016.12.1227

DO - 10.1016/j.jvir.2016.12.1227

M3 - Article

C2 - 28258801

AN - SCOPUS:85014055922

VL - 28

SP - 645

EP - 654

JO - Journal of Vascular and Interventional Radiology

JF - Journal of Vascular and Interventional Radiology

SN - 1051-0443

IS - 5

ER -